T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Healthcare | 16.09% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Alexandria Real Estate Equities
ARE
$8.27B
| $742M | 0.07% |
3,328,615
+228,604
| +7% | +$47.3M |
|
277
General Motors
GM
$76.1B
| $736M | 0.07% |
12,545,032
+9,076,503
| +262% | +$530M |
|
278
L3Harris
LHX
$54.1B
| $731M | 0.07% |
3,427,579
+9,650
| +0.3% | +$2.14M |
|
279
Broadridge
BR
$19.3B
| $723M | 0.07% |
3,953,757
-462,016
| -10% | -$81.2M |
|
280
Domino's
DPZ
$11.7B
| $721M | 0.06% |
1,277,596
-5,426
| -0.4% | -$2.76M |
|
281
Eversource Energy
ES
$26.9B
| $715M | 0.06% |
7,858,203
+264,088
| +3% | +$22.7M |
|
282
Franco-Nevada
FNV
$45.5B
| $714M | 0.06% |
5,157,274
+100,284
| +2% | +$13.9M |
|
283
Huazhu Hotels Group
HTHT
$12.7B
| $712M | 0.06% |
19,076,825
+3,991,829
| +26% | +$174M |
|
284
Endava
DAVA
$162M
| $707M | 0.06% |
4,210,823
+365,574
| +10% | +$56.6M |
|
285
Bunge Global
BG
$21.5B
| $706M | 0.06% |
7,566,263
-1,519,629
| -17% | -$136M |
|
286
Packaging Corp of America
PKG
$22.8B
| $700M | 0.06% |
5,142,564
-3,599,248
| -41% | -$484M |
|
287
Hubbell
HUBB
$27.1B
| $697M | 0.06% |
3,344,626
+211,317
| +7% | +$42.3M |
|
288
Align Technology
ALGN
$12.4B
| $695M | 0.06% |
1,058,011
-16,415
| -2% | -$10.6M |
|
289
VeriSign
VRSN
$25.6B
| $692M | 0.06% |
2,728,300
-159,245
| -6% | -$36.8M |
|
290
Lattice Semiconductor
LSCC
$18.4B
| $692M | 0.06% |
8,986,089
-683,122
| -7% | -$50.7M |
|
291
Kodiak Sciences
KOD
$2.72B
| $688M | 0.06% |
8,116,462
+60,232
| +0.7% | +$6.13M |
|
292
Rayonier
RYN
$6.47B
| $687M | 0.06% |
18,755,647
-146,652
| -0.8% | -$5.1M |
|
293
FirstEnergy
FE
$27.2B
| $678M | 0.06% |
16,309,429
+467,273
| +3% | +$18M |
|
294
CrowdStrike
CRWD
$226B
| $673M | 0.06% |
13,142,652
-240,428
| -2% | -$14.6M |
|
295
Boston Beer
SAM
$1.89B
| $669M | 0.06% |
1,324,015
-159,325
| -11% | -$79.6M |
|
296
Conagra Brands
CAG
$7.16B
| $669M | 0.06% |
19,576,485
-930,061
| -5% | -$30.5M |
|
297
Clear Secure
YOU
$4.75B
| $668M | 0.06% |
21,291,103
+331,504
| +2% | +$12.2M |
|
298
Yum China
YUMC
$16.4B
| $668M | 0.06% |
13,399,252
-414,155
| -3% | -$22.5M |
|
299
GSK
GSK
$101B
| $667M | 0.06% |
12,096,159
+273,665
| +2% | +$14.2M |
|
|
SRCL
300
DELISTED
Stericycle Inc
SRCL
| $660M | 0.06% |
11,062,819
+1,241,967
| +13% | +$77.8M |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.